Industry View: Consequences of the New Variations Regulation for the ECTD




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: Electronic submissions can substantially reduce submission time, allowing for a quicker release of products onto the market. However, the implementation and handling of eCTD can be problematic due to different standards at each European agency. In this interview Dr. Hannes